in

Collaboration between SunWay Biotech and Gnosis by Lesaffre results in powerful heart health supplement combining vitamin K2 and red yeast rice extract

MenaQ7 Metabolic combines two key active ingredients, MenaQ7 Vitamin K2 as MK-7 and ANKASCIN 568-R, which is extracted from fermented products of a patented functional red yeast strain, Monascus purpureus NTU 568.

“This innovative formula not only addresses the root causes of metabolic issues but also provides a holistic approach to maintaining heart health, bone strength, and optimal metabolic functions. The extensive clinical research behind both MenaQ7 and ANKASCIN 568-R underpins the effectiveness of this unique blend, making it a pivotal choice for those seeking to improve their cardiometabolic health,”​ said John Pan, General Manager of Sunway Biotech.

The rising demand for vitamin K2 and red yeast rice extract

Pan observed that there is a preference for richer, more flavourful foods, especially in the APAC region. When combined with high sugar and fat content, such a diet could lead to an increased risk of metabolic syndrome.

He believes that this is a main driving force behind the rise in demand for cardiometabolic health supplements with vitamin K2 and red yeast rice extracts.

Pan points out that the vitamin K2 market is projected to grow at a CAGR of between 10 to 15% from 2021 to 2025. This upward trend is driven by an escalating demand for vitamin K2-enriched products, as evidenced by a more than 30% increase in product launches since 2015.

As for red yeast rice supplements, the market was valued at $525.9 million in 2022 and is expected to grow at a CAGR of 8.04% from 2023 to 2030, reaching $972.4 million by 2030.

“The collaboration between SunWay Biotech and Gnosis by Lesaffre to launch MenaQ7® Metabolic underscores the dynamic growth in this segment, offering a synthetic-chemical-free solution for cardiovascular health. This resonates with the increasing consumer demand for safer, more natural health solutions,”​ said Pan.

What do you think?

Written by The Muscle Mag

New possibilities for DAO delivery with AB Biotek’s HNH microencapsulated ingredient

Arla purchases Volac’s Whey Nutrition division